Suppr超能文献

植入式静脉通路导管的并发症及处理

Complications and management of implanted venous access catheters.

作者信息

Lokich J J, Bothe A, Benotti P, Moore C

出版信息

J Clin Oncol. 1985 May;3(5):710-7. doi: 10.1200/JCO.1985.3.5.710.

Abstract

A totally implanted subclavian venous access system composed of a reservoir and silastic catheter was employed in 92 patients receiving infusion chemotherapy and/or hyperalimentation. The major catheter complication was subclavian or jugular vein thrombosis observed in 15 patients (16%). Thrombosis was observed in the ipsilateral subclavian or jugular vein surrounding the catheter without restricting function, except in two patients with thrombosis in the vein at the end of the catheter. Prophylaxis with low-dose Coumadin was effective in preventing thrombosis in high-risk patients as defined by a history of prior thrombosis. Streptokinase and/or heparin relieved the signs and symptoms of thrombosis, but clot dissolution or reversal of collateral flow was not observed. Explantation of the catheter was not necessary in all patients in that embolic complications of the thrombosis were not observed, and the system was retained and functioned in five patients in spite of the presence of thrombosis around the catheter. Other complications of the implanted system include "pocket" infection, catheter migration, and occlusion. Most complications may be managed without obligate catheter removal.

摘要

92例接受输注化疗和/或胃肠外营养的患者使用了由贮液器和硅橡胶导管组成的完全植入式锁骨下静脉通路系统。主要的导管并发症是15例患者(16%)出现锁骨下或颈静脉血栓形成。血栓形成于导管周围的同侧锁骨下或颈静脉,除2例导管末端静脉血栓形成的患者外,其余患者的功能均未受限。对于有既往血栓形成病史定义的高危患者,低剂量香豆素预防血栓形成有效。链激酶和/或肝素缓解了血栓形成的体征和症状,但未观察到血栓溶解或侧支血流逆转。并非所有患者都需要取出导管,因为未观察到血栓形成的栓塞并发症,尽管导管周围存在血栓形成,该系统仍在5例患者中保留并发挥功能。植入系统的其他并发症包括“囊袋”感染、导管移位和堵塞。大多数并发症无需取出导管即可处理。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验